To further validate reproducibility of the results obtained in the profiling phase of the study, plasma levels of the lncRNAs BC200, NDM29, NEAT1, FAS-AS1 and GAS5-AS1 in all AD and healthy controls were assessed by qRT-PCR and compared between two groups. This evidence concerns the gene FAS and Alzheimer disease.